Winton Group’s Agilon Health AGL Stock Holding History

Winton Group’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,846	Closed	-$106K	–	711
2025 Q2	$106K	Buy	+1,846	New	+$148K	0.01%	782
2023 Q2	–	Sell	-852	Closed	-$506K	–	762
2023 Q1	$506K	Buy	+852	New	+$477K	0.03%	677

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Winton Group's AGL Position: Q3 2025 in Review

Winton Group sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 1,846 shares — an estimated $106K sold.

Winton Group first reported a position in AGL in Q1 2023 and held it in 2 quarters. The position peaked at $506K in Q1 2023. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

Winton Group reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
Winton Group sold 1,846 Agilon Health shares in Q3 2025, an estimated $106K.
Winton Group first reported a position in Agilon Health in Q1 2023 and held it in 2 quarters.
Winton Group's Agilon Health position peaked at $506K in Q1 2023.
190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Winton Group's 13F filing for Q3 2025, filed 13 Nov 2025.